In adults, death has been reported after 5 g. The usual lethal dose is 10 to 20g, although survival after a dose of 28 g has been reported.
Glutethimide is a hypnotic and sedative. Its use has been largely superseded by other drugs.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Glutethimide. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Glutethimide. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Glutethimide. |
| Hydrocodone | Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Glutethimide. |
| Magnesium sulfate | The therapeutic efficacy of Glutethimide can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Glutethimide may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Glutethimide. |
| Mirtazapine | Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Glutethimide. |
| Orphenadrine | Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Glutethimide. |
| Pramipexole | Glutethimide may increase the sedative activities of Pramipexole. |
| Ropinirole | Glutethimide may increase the sedative activities of Ropinirole. |
| Rotigotine | Glutethimide may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Glutethimide. |
| Suvorexant | Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Glutethimide. |
| Thalidomide | Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Glutethimide. |
| Sodium oxybate | Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Dicoumarol | The therapeutic efficacy of Dicoumarol can be decreased when used in combination with Glutethimide. |
| Phenindione | The therapeutic efficacy of Phenindione can be decreased when used in combination with Glutethimide. |
| Warfarin | The therapeutic efficacy of Warfarin can be decreased when used in combination with Glutethimide. |
| Phenprocoumon | The therapeutic efficacy of Phenprocoumon can be decreased when used in combination with Glutethimide. |
| Acenocoumarol | The therapeutic efficacy of Acenocoumarol can be decreased when used in combination with Glutethimide. |
| 4-hydroxycoumarin | The therapeutic efficacy of 4-hydroxycoumarin can be decreased when used in combination with Glutethimide. |
| Coumarin | The therapeutic efficacy of Coumarin can be decreased when used in combination with Glutethimide. |
| (R)-warfarin | The therapeutic efficacy of (R)-warfarin can be decreased when used in combination with Glutethimide. |
| Ethyl biscoumacetate | The therapeutic efficacy of Ethyl biscoumacetate can be decreased when used in combination with Glutethimide. |
| Fluindione | The therapeutic efficacy of Fluindione can be decreased when used in combination with Glutethimide. |
| Clorindione | The therapeutic efficacy of Clorindione can be decreased when used in combination with Glutethimide. |
| Diphenadione | The therapeutic efficacy of Diphenadione can be decreased when used in combination with Glutethimide. |
| Tioclomarol | The therapeutic efficacy of Tioclomarol can be decreased when used in combination with Glutethimide. |
| (S)-Warfarin | The therapeutic efficacy of (S)-Warfarin can be decreased when used in combination with Glutethimide. |
| Ethanol | Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Glutethimide. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Glutethimide is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Glutethimide is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Glutethimide is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Glutethimide is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Glutethimide is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Glutethimide is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Glutethimide is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Glutethimide is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Glutethimide is combined with Escitalopram. |
| Zimelidine | The risk or severity of adverse effects can be increased when Glutethimide is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Glutethimide is combined with Dapoxetine. |
| Milnacipran | The risk or severity of adverse effects can be increased when Glutethimide is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Glutethimide is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Glutethimide is combined with Seproxetine. |
| Indalpine | The risk or severity of adverse effects can be increased when Glutethimide is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Glutethimide is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Glutethimide is combined with Alaproclate. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Glutethimide. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Glutethimide. |
| Maprotiline | The risk or severity of CNS depression can be increased when Maprotiline is combined with Glutethimide. |
| Pizotifen | The risk or severity of CNS depression can be increased when Glutethimide is combined with Pizotifen. |
| Amitriptyline | The risk or severity of CNS depression can be increased when Amitriptyline is combined with Glutethimide. |
| Imipramine | The risk or severity of CNS depression can be increased when Imipramine is combined with Glutethimide. |
| Nortriptyline | The risk or severity of CNS depression can be increased when Nortriptyline is combined with Glutethimide. |
| Amoxapine | The risk or severity of CNS depression can be increased when Amoxapine is combined with Glutethimide. |
| Doxepin | The risk or severity of CNS depression can be increased when Doxepin is combined with Glutethimide. |
| Desipramine | The risk or severity of CNS depression can be increased when Desipramine is combined with Glutethimide. |
| Dosulepin | The risk or severity of CNS depression can be increased when Glutethimide is combined with Dosulepin. |
| Zopiclone | The risk or severity of adverse effects can be increased when Glutethimide is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Glutethimide. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Glutethimide. |
| Tryptophan | The risk or severity of CNS depression can be increased when Tryptophan is combined with Glutethimide. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Glutethimide. |
| Lorazepam | The risk or severity of CNS depression can be increased when Lorazepam is combined with Glutethimide. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Glutethimide. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Glutethimide. |
| Reserpine | The risk or severity of CNS depression can be increased when Reserpine is combined with Glutethimide. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Glutethimide. |
| Temazepam | The risk or severity of CNS depression can be increased when Temazepam is combined with Glutethimide. |
| Reboxetine | The risk or severity of CNS depression can be increased when Reboxetine is combined with Glutethimide. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Glutethimide. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Glutethimide. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Glutethimide. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Glutethimide. |
| Phenytoin | The risk or severity of CNS depression can be increased when Phenytoin is combined with Glutethimide. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Glutethimide. |
| Clemastine | The risk or severity of CNS depression can be increased when Clemastine is combined with Glutethimide. |
| Venlafaxine | The risk or severity of CNS depression can be increased when Venlafaxine is combined with Glutethimide. |
| Etomidate | The risk or severity of CNS depression can be increased when Etomidate is combined with Glutethimide. |
| Morphine | The risk or severity of CNS depression can be increased when Morphine is combined with Glutethimide. |
| Talbutal | The risk or severity of CNS depression can be increased when Talbutal is combined with Glutethimide. |
| Pentobarbital | The risk or severity of CNS depression can be increased when Pentobarbital is combined with Glutethimide. |
| Valproic acid | The risk or severity of CNS depression can be increased when Valproic acid is combined with Glutethimide. |
| Zolmitriptan | The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Glutethimide. |
| Codeine | The risk or severity of CNS depression can be increased when Codeine is combined with Glutethimide. |
| Dihydroergotamine | The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Glutethimide. |
| Tolcapone | The risk or severity of CNS depression can be increased when Tolcapone is combined with Glutethimide. |
| Hydromorphone | The risk or severity of CNS depression can be increased when Hydromorphone is combined with Glutethimide. |